22 hours Ago By Defense World Staff
Healthpeak Properties, Inc. (NYSE:DOC – Free Report) – Analysts at Wedbush lowered their FY2026 earnings per share (EPS) estimates for Healthpeak Properties in a note issued to investors on Monday, April 28th. Wedbush analyst R.
Anderson now expects that the real estate investment trust will earn $1.95 per share for the year, down from their previous estimate of $1.96.
Wedbush currently has a “Outperform” rating and a $22.00 target price on the stock. The consensus estimate for Healthpeak Properties’ current full-year earnings is $1.
86 per share. Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.
46 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.46. Healthpeak Properties had a return on equity of 2.
61% and a net margin of 9.00%. The firm had revenue of $702.
89 million for the quarter, compared to analysts’ expectations of $690.76 million. During the same period in the prior year, the business posted $0.
45 earnings per share. The business’s revenue was up 15.9% compared to the same quarter last year.
DOC has been the topic of several other reports. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective on the stock in a report on Wednesday, January 15th.
Evercore ISI reduced their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating for the company in a report on Monday.
StockNews.com downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, April 23rd. Robert W.
Baird dropped their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a research report on Tuesday.
Finally, Argus reiterated a “buy” rating and set a $25.00 price objective on shares of Healthpeak Properties in a research report on Tuesday. One analyst has rated the stock with a sell rating, three have given a hold rating and nine have given a buy rating to the company.
According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $23.42.Get Our Latest Analysis on DOCHealthpeak Properties Trading Up 0.
2 %DOC opened at $17.78 on Tuesday. Healthpeak Properties has a 1-year low of $17.
33 and a 1-year high of $23.26. The firm has a 50-day moving average price of $19.
49 and a two-hundred day moving average price of $20.51. The stock has a market capitalization of $12.
44 billion, a PE ratio of 50.80, a PEG ratio of 2.17 and a beta of 1.
02. The company has a current ratio of 1.35, a quick ratio of 1.
35 and a debt-to-equity ratio of 0.96. Healthpeak Properties Dividend AnnouncementThe company also recently announced a dividend, which will be paid on Wednesday, April 30th.
Shareholders of record on Friday, April 18th will be given a $0.1017 dividend. The ex-dividend date of this dividend is Thursday, April 17th.
This represents a yield of 6.5%. Healthpeak Properties’s dividend payout ratio is presently 305.
00%. Insiders Place Their BetsIn other news, CEO Scott M. Brinker bought 11,337 shares of the stock in a transaction that occurred on Monday, April 28th.
The stock was acquired at an average price of $17.68 per share, with a total value of $200,438.16.
Following the completion of the purchase, the chief executive officer now directly owns 201,863 shares of the company’s stock, valued at approximately $3,568,937.84. This represents a 5.
95 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Also, Director John T.
Thomas bought 4,200 shares of the firm’s stock in a transaction that occurred on Monday, April 28th. The shares were acquired at an average cost of $17.84 per share, with a total value of $74,928.
00. Following the purchase, the director now directly owns 813,566 shares of the company’s stock, valued at $14,514,017.44.
This trade represents a 0.52 % increase in their ownership of the stock. The disclosure for this purchase can be found here.
Insiders own 0.23% of the company’s stock. Institutional Inflows and OutflowsA number of large investors have recently modified their holdings of DOC.
JPMorgan Chase & Co. increased its holdings in Healthpeak Properties by 23.2% during the third quarter.
JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after buying an additional 4,056,931 shares during the last quarter. Geode Capital Management LLC boosted its stake in Healthpeak Properties by 3.
6% during the fourth quarter. Geode Capital Management LLC now owns 18,355,772 shares of the real estate investment trust’s stock valued at $371,168,000 after buying an additional 638,012 shares during the period. Principal Financial Group Inc.
grew its holdings in shares of Healthpeak Properties by 2,113.5% during the fourth quarter. Principal Financial Group Inc.
now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after purchasing an additional 17,314,572 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its holdings in shares of Healthpeak Properties by 10.
6% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 17,267,917 shares of the real estate investment trust’s stock worth $350,021,000 after buying an additional 1,651,235 shares during the last quarter.
Finally, Centersquare Investment Management LLC lifted its stake in Healthpeak Properties by 3.7% during the fourth quarter. Centersquare Investment Management LLC now owns 11,215,516 shares of the real estate investment trust’s stock worth $227,339,000 after purchasing an additional 398,770 shares during the last quarter.
Institutional investors own 93.57% of the company’s stock. About Healthpeak Properties (Get Free Report)Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company.
Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery. Read MoreFive stocks we like better than Healthpeak PropertiesLarge Cap Stock Definition and How to InvestDon’t Be Fooled by the Bounce: The Market Storm Isn’t Over YetHow to Read Stock Charts for BeginnersCoca-Cola Company Stock Can Bubble to New Highs This YearWhat Are Dividend Contenders? Investing in Dividend Contenders3 Stocks Lifting 2025 Guidance Despite Market Jitters.
